ABCDx signs partnership agreement with PolarCool for TBICheck ™ covering the Nordic market


ABCDx has entered into a partnership agreement with the Swedish based company PolarCool AB for evaluation and potential sales rights in the Nordic region for TBICheck ™, a portable device for detection of mild traumatic brain injury. The partnership agreement provides the opportunity for PolarCool to obtain an exclusive distributor agreement for the sale of TBICheck ™ in the Nordic sports market, and a non-exclusive distributor agreement in the Nordic healthcare market. ABCDx could thereby enter the sports segment in the Nordic countries through the privileged access of PolarCool networks.

TBICheck ™ is a new rapid blood finger point-of-care test for early diagnostic and decision process. The tool measures a panel of biomarkers in the blood. Within 15 minutes of taking a blood sample, TBICheck ™ will provide a diagnostic result, with high precision, determining the risk of incurred brain injury.